Global Surgical Glue Market is Set to Reach USD 7,835.1 Million by 2024

The global surgical glue market is expected to grow at a CAGR of 10.7% during the forecast period with its market size predicted to reach USD 7,835.1 million by 2024.

Growing number of cases for traumatic wounds across the globe are the major factors that are contributing to the growth of the global surgical glue market.

Request for Sample Copy at https://www.vynzresearch.com/chemicals-materials/surgical-glue-market/request-sample

Surgical glue is used in case of traumatic injuries and surgeries that avoid leakage of liquids or air in the wounds. Surgical glues are categorized in various forms such as fibrin sealants, hydrogels, cyanoacrylates, collagen-based compounds, and glutaraldehyde glues.

Asia-Pacific is expected to witness the fastest growth in the global surgical glue market owing to increasing geriatric population, increasing emphasis of key market players in the developing countries of this regions, escalating demand for surgical intermediations, extensive industrial growth and increasing implementation of progressive and upgraded medical devices due to rapid demand for superior quality products are the significant factors driving the growth of this market in this region.

Some of the major players operating in the global surgical glue market include B. Braun Melsungen AG, Baxter International Inc., Advanced Medical Solutions Group PLC, C. R. Bard Inc., Cardinal Health Inc., CryoLife Inc., Integra LifeSciences Holdings Corporation, Cohera Medical Inc., Takeda Pharmaceutical Company Limited., Johnson & Johnson, and Medtronic PLC.

Source: VynZ Research